Khawaja Z, Wilcox C S
Division of Nephrology and Hypertension, Georgetown University Medical Center, 3800 Reservoir Road NW, PHC F6003, Washington, DC 20007, USA.
Int J Hypertens. 2011 Mar 14;2011:143471. doi: 10.4061/2011/143471.
Resistant hypertension is a failure to achieve goal BP (<140/90 mm Hg for the overall population and <130/80 mm Hg for those with diabetes mellitus or chronic kidney disease) in a patient who adheres to maximum tolerated doses of 3 antihypertensive drugs including a diuretic. The kidneys play a critical role in long-term regulation of blood pressure. Blunted pressure natriuresis, with resultant increase in extracellular fluid volume, is an important cause of resistant hypertension. Activation of the renin-angiotensin-aldosterone system, increased renal sympathetic nervous system activity and increased sodium reabsorption are important renal mechanisms. Successful treatment requires identification and reversal of lifestyle factors or drugs contributing to treatment resistance, diagnosis and appropriate treatment of secondary causes of hypertension, use of effective multidrug regimens and optimization of diuretic therapy. Since inappropriate renal salt retention underlies most cases of drug-resistant hypertension, the therapeutic focus should be on improving salt depleting therapy by assessing and, if necessary, reducing dietary salt intake, optimizing diuretic therapy, and adding a mineralocorticoid antagonist if there are no contraindications.
顽固性高血压是指在坚持使用包括利尿剂在内的3种最大耐受剂量降压药物治疗的患者中,血压仍未达到目标值(一般人群<140/90 mmHg,糖尿病或慢性肾脏病患者<130/80 mmHg)。肾脏在血压的长期调节中起关键作用。压力性利钠作用减弱,导致细胞外液量增加,是顽固性高血压的重要原因。肾素-血管紧张素-醛固酮系统激活、肾交感神经系统活性增加以及钠重吸收增加是重要的肾脏机制。成功治疗需要识别并纠正导致治疗抵抗的生活方式因素或药物,诊断并适当治疗高血压的继发原因,使用有效的联合用药方案并优化利尿剂治疗。由于不适当的肾盐潴留是大多数耐药性高血压病例的基础,治疗重点应是通过评估并在必要时减少饮食盐摄入量、优化利尿剂治疗以及在无禁忌证时加用盐皮质激素拮抗剂来改善排盐治疗。